{
  "id": 1462,
  "text": "5 4 – 3 .6 3$ )).Compared with radiotherapy and CCRT (cisplatin), the 5-year OS rate of CCRT (hydroxyurea) was lower $\\mathrm { \\Delta } \\operatorname { \\left[ O R \\right] } = 0 .4 9$ $9 5 \\% \\mathrm { C I } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 5 4 – 3 .6 3$ )).Compared with radiotherapy and CCRT (cisplatin), the 5-year OS rate of CCRT (hydroxyurea) was lower $\\mathrm { \\Delta } \\operatorname { \\left[ O R \\right] } = 0 .4 9$ $9 5 \\% \\mathrm { C I } = 0 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据所提到的内容，在宫颈癌的治疗方案中，比较放疗、顺铂联合同步放化疗（CCRT）和羟基尿联合化疗（CCRT），羟基尿联合化疗方案在5年总生存率方面表现较其他方案更低。与放疗和顺铂的CCRT相比，羟基尿的CCRT的5年总生存率更低，差异值为0.49，表明羟基尿联合化疗在提高患者长期生存率方面较其他方案不占优势。",
  "query": "根据您提到的内容，请问能够比较不同治疗方案（如放疗、顺铂与羟基尿的联合化疗）在患者的5年总生存率上有何差异？尤其是羟基尿联合化疗方案较其他方案在总生存率上是否有更低的表现？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据您提到的内容，请问能够比较不同治疗方案（如放疗、顺铂与羟基尿的联合化疗）在患者的5年总生存率上有何差异？尤其是羟基尿联合化疗方案较其他方案在总生存率上是否有更低的表现？\n\n<reference text>: 5 4 – 3 .6 3$ )).Compared with radiotherapy and CCRT (cisplatin), the 5-year OS rate of CCRT (hydroxyurea) was lower $\\mathrm { \\Delta } \\operatorname { \\left[ O R \\right] } = 0 .4 9$ $9 5 \\% \\mathrm { C I } = 0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据所提到的内容，在宫颈癌的治疗方案中，比较放疗、顺铂联合同步放化疗（CCRT）和羟基尿联合化疗（CCRT），羟基尿联合化疗方案在5年总生存率方面表现较其他方案更低。与放疗和顺铂的CCRT相比，羟基尿的CCRT的5年总生存率更低，差异值为0.49，表明羟基尿联合化疗在提高患者长期生存率方面较其他方案不占优势。"
}